Submitted by Anonymous (not verified) on 19 August 2025 - 13:12
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 2, Status: Authorised
Source: